Supplier News

Jan 10, 2018
By BioPharm International Editors
Pharma Team Up has launched Poseidon, an integrated ocean freight program, to address the disconnect between pharma companies and their logistics providers.
Jan 08, 2018
By BioPharm International Editors
AptarGroup’s Landfill Free Certification program addresses the issue of waste production from pharmaceutical manufacturing processes by prompting its facilities to reduce and reuse operation waste.
Jan 04, 2018
By BioPharm International Editors
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
Jan 04, 2018
By BioPharm International Editors
The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.
Dec 28, 2017
By BioPharm International Editors
The biotechnology company has filed for FDA approval of a new plasma manufacturing facility in Covington, GA, to support its immunology franchise.
Dec 28, 2017
By BioPharm International Editors
The companies have entered an agreement involving assay development and the manufacturing of kits supporting biomarker research programs.
Dec 20, 2017
By BioPharm International Editors
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
Dec 19, 2017
By BioPharm International Editors
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.
Dec 19, 2017
By BioPharm International Editors
BioTek Instruments has released a second edition of its BioSpa software that now offers users a simplified but effective interface for kinetic imaging or detection workflows.
Dec 14, 2017
By BioPharm International Editors
Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate (ADC) to clinical trials.
native1_300x100
lorem ipsum